Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03271307 |
Recruitment Status :
Completed
First Posted : September 5, 2017
Results First Posted : December 2, 2020
Last Update Posted : December 2, 2020
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Diagnostic |
Condition |
HIV Infections |
Interventions |
Behavioral: Optimized PITC Diagnostic Test: Facility HIVST Diagnostic Test: Index HIVST |
Enrollment | 6369 |
Recruitment Details | Participants were recruited during routine health services at participating facilities. For Aim 1, participants were recruited from September 18, 2017 - February 19, 2018. For Aim 2, participants were recruited from March 21, 2018 - June 13, 2018. |
Pre-assignment Details |
Arm/Group Title | AIm 1: Standard of Care | Aim 1: Optimized Standard of Care | Aim 1: Facility HIVST | Aim 2: Standard of Care | Aim 2: Index HIVST | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
Facilities assigned to the standard of care arm will receive no intervention and will continue with Ministry of Health National HIV Guidelines for provider-initiated testing and counseling (PITC) for outpatients in Aim 1. PITC guidelines recommend providers inform their OPD clients about HIV testing and refer them to HIV testing services at the facility. |
Facilities assigned to the optimized standard of care arm will receive additional guidance and support from the study team to adopt the Ministry of Health National HIV Guidelines for provider-initiated testing and counseling (PITC) for Aim 1. Optimized PITC: Providers will receive training on the importance of HIV testing and their role in testing as part of OPD care and morning HIV testing will be offered. Providers will receive job aids on the importance of referring patients for HIV testing, and the study team will conduct regular monitoring and evaluation on PITC implementation. |
Facilities assigned to the HIVST arm will implement HIVST procedures in lieu of recommendations provided by the Ministry of Health National HIV Guidelines (PITC). Facility HIVST: HIVST will be carried out in a group setting among patients in the waiting area of OPD clinics. Eligible clients will receive education about HIV testing and a demonstration of how to use and interpret results of a self-test kit will occur in the group setting. Participants will use the HIVST kit in a group setting and will be given private settings (private room or booth) to interpret their results. Participants will disclose their results to their OPD provider if they choose. Routine linkage to confirmatory testing and ART initiation will be conducted. |
Facilities assigned to the standard of care arm will receive no intervention and will continue with Ministry of Health National HIV Guidelines for index HIV testing for sexual partners of HIV-positive clients. Partner referral slips will be given to HIV-positive clients to encourage partner testing. |
Facilities assigned to the HIVST arm will implement HIVST procedures in lieu of recommendations provided by the Ministry of Health National HIV Guidelines (partner referral slips). Index HIVST: HIVST demonstration and distribution will be provided to HIV-positive clients in participating facilities to distribute to their partners. Partners who have a reactive HIVST test result, or are unable or unwilling to use HIVST, will be asked to present at the health facility for routine HIV testing. Routine linkage to confirmatory testing and ART initiation will be conducted. |
||||||
Period Title: Overall Study | |||||||||||
Number of participants | Number of units (Facilities) | Number of participants | Number of units (Facilities) | Number of participants | Number of units (Facilities) | Number of participants | Number of units (Facilities) | Number of participants | Number of units (Facilities) | ||
Started | 1951 | 5 | 1837 | 5 | 2097 | 5 | 135 | 1 | 349 | 2 | |
Completed | 1951 | 5 | 1837 | 5 | 2097 | 5 | 107 | 1 | 258 | 2 | |
Not Completed | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 0 | 91 | 0 | |
Reason Not Completed | |||||||||||
Lost to Follow-up | 0 | 0 | 0 | 28 | 91 |
Arm/Group Title | AIm 1: Standard of Care | Aim 1: Optimized Standard of Care | Aim 1: Facility HIVST | Aim 2: Standard of Care | Aim 2: Index HIVST | Total | |
---|---|---|---|---|---|---|---|
![]() |
Facilities assigned to the standard of care arm will receive no intervention and will continue with Ministry of Health National HIV Guidelines for provider-initiated testing and counseling (PITC) for outpatients in Aim 1. PITC guidelines recommend providers inform their OPD clients about HIV testing and refer them to HIV testing services at the facility. |
Facilities assigned to the optimized standard of care arm will receive additional guidance and support from the study team to adopt the Ministry of Health National HIV Guidelines for provider-initiated testing and counseling (PITC) for Aim 1. Optimized PITC: Providers will receive training on the importance of HIV testing and their role in testing as part of OPD care and morning HIV testing will be offered. Providers will receive job aids on the importance of referring patients for HIV testing, and the study team will conduct regular monitoring and evaluation on PITC implementation. |
Facilities assigned to the HIVST arm will implement HIVST procedures in lieu of recommendations provided by the Ministry of Health National HIV Guidelines (PITC). Facility HIVST: HIVST will be carried out in a group setting among patients in the waiting area of OPD clinics. Eligible clients will receive education about HIV testing and a demonstration of how to use and interpret results of a self-test kit will occur in the group setting. Participants will use the HIVST kit in a group setting and will be given private settings (private room or booth) to interpret their results. Participants will disclose their results to their OPD provider if they choose. Routine linkage to confirmatory testing and ART initiation will be conducted. |
Facilities assigned to the standard of care arm will receive no intervention and will continue with Ministry of Health National HIV Guidelines for index HIV testing for sexual partners of HIV-positive clients. Partner referral slips will be given to HIV-positive clients to encourage partner testing. |
Facilities assigned to the HIVST arm will implement HIVST procedures in lieu of recommendations provided by the Ministry of Health National HIV Guidelines (partner referral slips). Index HIVST: HIVST demonstration and distribution will be provided to HIV-positive clients in participating facilities to distribute to their partners. Partners who have a reactive HIVST test result, or are unable or unwilling to use HIVST, will be asked to present at the health facility for routine HIV testing. Routine linkage to confirmatory testing and ART initiation will be conducted. |
Total of all reporting groups | |
Overall Number of Baseline Participants | 1951 | 1837 | 2097 | 135 | 349 | 6369 | |
![]() |
[Not Specified]
|
||||||
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
|||||||
Number Analyzed | 1951 participants | 1837 participants | 2097 participants | 135 participants | 349 participants | 6369 participants | |
<=18 years |
280 14.4%
|
223 12.1%
|
264 12.6%
|
5 3.7%
|
6 1.7%
|
778 12.2%
|
|
Between 18 and 65 years |
1594 81.7%
|
1543 84.0%
|
1800 85.8%
|
126 93.3%
|
337 96.6%
|
5400 84.8%
|
|
>=65 years |
77 3.9%
|
71 3.9%
|
33 1.6%
|
4 3.0%
|
6 1.7%
|
191 3.0%
|
|
Age, Continuous
Median (Inter-Quartile Range) Unit of measure: Years |
|||||||
Number Analyzed | 1951 participants | 1837 participants | 2097 participants | 135 participants | 349 participants | 6369 participants | |
27
(26 to 35)
|
36
(25 to 48)
|
35
(28 to 44)
|
35
(29 to 45)
|
36
(28 to 43)
|
35
(27 to 44)
|
||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
|||||||
Number Analyzed | 1951 participants | 1837 participants | 2097 participants | 135 participants | 349 participants | 6369 participants | |
Female |
1327 68.0%
|
1002 54.5%
|
1304 62.2%
|
105 77.8%
|
266 76.2%
|
4004 62.9%
|
|
Male |
624 32.0%
|
835 45.5%
|
793 37.8%
|
30 22.2%
|
83 23.8%
|
2365 37.1%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
|||||||
Number Analyzed | 1951 participants | 1837 participants | 2097 participants | 135 participants | 349 participants | 6369 participants | |
American Indian or Alaska Native |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Asian |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Native Hawaiian or Other Pacific Islander |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Black or African American |
1951 100.0%
|
1837 100.0%
|
2097 100.0%
|
135 100.0%
|
349 100.0%
|
6369 100.0%
|
|
White |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
More than one race |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Unknown or Not Reported |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Region of Enrollment
Measure Type: Count of Participants Unit of measure: Participants |
|||||||
Malawi | Number Analyzed | 1951 participants | 1837 participants | 2097 participants | 135 participants | 349 participants | 6369 participants |
1951 100.0%
|
1837 100.0%
|
2097 100.0%
|
135 100.0%
|
349 100.0%
|
6369 100.0%
|
||
Tested for HIV ≥3months ago
Measure Type: Count of Participants Unit of measure: Participants |
|||||||
Number Analyzed | 1951 participants | 1837 participants | 2097 participants | 135 participants | 349 participants | 6369 participants | |
625 32.0%
|
508 27.7%
|
320 15.3%
|
0 0.0%
|
0 0.0%
|
1453 22.8%
|
Name/Title: | Dr. Kathryn Dovel |
Organization: | University of California Los Angeles |
Phone: | 7143303416 |
EMail: | KDovel@mednet.ucla.edu |
Responsible Party: | Kathryn L. Dovel, PhD, University of California, Los Angeles |
ClinicalTrials.gov Identifier: | NCT03271307 |
Other Study ID Numbers: |
17-000109 |
First Submitted: | August 31, 2017 |
First Posted: | September 5, 2017 |
Results First Submitted: | May 15, 2019 |
Results First Posted: | December 2, 2020 |
Last Update Posted: | December 2, 2020 |